货号:GS40149
Cosfroviximab (c13C6-FR1) is an investigational chimeric (mouse/human) monoclonal antibody developed for research and potential therapeutic use against Ebola virus disease (EVD). It belongs to a class of biologics designed for passive immunotherapy, aiming to neutralize the virus and provide immediate, short-term protection or treatment. Its development is part of the broader effort to create effective antibody-based countermeasures against this highly lethal pathogen.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物